The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Aspirin 75mg gastro-resistant tablets

75 milligram(s) Gastro-resistant tablet

Clonmel Healthcare LtdPA0126/246/001

Main Information

Trade NameAspirin 75mg gastro-resistant tablets
Active SubstancesAcetyl salicylic acid
Strength75 milligram(s)
Dosage FormGastro-resistant tablet
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/246/001

Group Information

ATC CodeB01AC Platelet aggregation inhibitors excl. heparin
B01AC06 acetylsalicylic acid

Status

Authorised/WithdrawnAuthorised
Licence Issued14/02/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceShould the MAH wish to source active substance from Novacyl (Thailand) Limited, Thailand (the alternative active substance manufacturing site covered by the CEP), the appropriate variation application should be submitted accordingly.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back